(Q37759238)

22 August 2017

1 reference

title

Hyperglycemia: a prothrombotic factor? (English)

1 reference

22 August 2017

1 reference

B A Lemkes

1

1 reference

22 August 2017

J Hermanides

2

1 reference

22 August 2017

J H Devries

3

1 reference

22 August 2017

F Holleman

4

1 reference

22 August 2017

J C M Meijers

5

1 reference

22 August 2017

J B L Hoekstra

6

1 reference

22 August 2017

publication date

12 May 2010

1 reference

Journal of Thrombosis and Haemostasis

22 August 2017

published in

1 reference

22 August 2017

volume

8

1 reference

22 August 2017

issue

8

1 reference

22 August 2017

page(s)

1663-1669

1 reference

Diabetes mellitus: a hypercoagulable state

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Diabetes mellitus as a prothrombotic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Hypercoagulability in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Fibrinolysis and diabetic retinopathy in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

A prospective study of risk factors for pulmonary embolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Cardiovascular risk factors and venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

21 January 2018

Stress hyperglycaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Blood glucose may condition factor VII levels in diabetic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Tight glycemic control may favor fibrinolysis in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Intensive versus conventional glucose control in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Glucose normalization and outcomes in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Impact of acute hyperglycemia during primary stent implantation in patients with ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Acarbose reduces myocardial infarct size by preventing postprandial hyperglycemia and hydroxyl radical production and opening mitochondrial KATP channels in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2010.03910.X

10.1111/J.1538-7836.2010.03910.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference